[ad_1]
The launch of the drug is welcome news for diabetic patients with insulin resistance, which happens to be a common problem in India with every four out of ten diabetic patients showing insulin resistance in India.
[ad_2]
Source link
(This article is generated through the syndicated feed sources, Financetin doesn’t own any part of this article)
